Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1Dermatologic 1

Conditions

Multiple Myeloma 13Recurrence 9Neoplasms 8Colorectal Neoplasms 8Pancreatic Neoplasms 7Leukemia, Myeloid, Acute 7Hematologic Neoplasms 7Carcinoma, Hepatocellular 7Lymphoma, B-Cell 6Sarcoma 5Prostatic Neoplasms 5Breast Neoplasms 5Neoplasms, Plasma Cell 4Myasthenia Gravis 4Lymphoma 4Lung Neoplasms 4Glioblastoma 4Burkitt Lymphoma 4Brain Neoplasms 4Advanced Solid Tumors 4Stomach Neoplasms 3Solid Tumor 3Ovarian Neoplasms 3Melanoma 3Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3Head and Neck Neoplasms 3Glioma 3Carcinoma, Non-Small-Cell Lung 3Squamous Cell Carcinoma of Head and Neck 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Not yet recruiting × Urogenital Neoplasms × Clear all
NCT07389525 2026-04-24

Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study

Indiana University

Phase EARLY_PHASE1 Not yet recruiting
80 enrolled
DermatologicGastrointestinalSarcoma

Gastrointestinal Neoplasms, Melanoma, Sarcoma, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡